✦ LIBER ✦

Metabolic studies in Wilson's disease: Evaluation of efficacy of chelation therapy in respect to copper balance

✍ Scribed by G.Thomas Strickland; R.Quentin Blackwell; Raymond H. Watten

Book ID: 115675899
Publisher: Elsevier Science
Year: 1971
Tongue: English
Weight: 927 KB
Volume: 51
Category: Article
ISSN: 1555-7162
DOI: 10.1016/0002-9343(71)90321-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Metabolism of copper in Wilson's disease

Metabolism of copper in Wilson's disease and in normal subjects: Studies with Cu-64

✍ C.J. Earl; Mildred Jewett Moulton; Bertram Selverstone 📂 Article 📅 1954 🏛 Elsevier Science 🌐 English ⚖ 824 KB

A critical evaluation of copper metaboli

A critical evaluation of copper metabolism in indian wilson’s disease children with special reference to their phenotypes and relatives

✍ Rajendra Prasad; Gurjit Kaur; B. N. S. Walia 📂 Article 📅 1998 🏛 Humana Press Inc 🌐 English ⚖ 906 KB

Studies on copper metabolism XXIX: A cri

Studies on copper metabolism XXIX: A critical analysis of serum copper and ceruloplasmin concentrations in normal subjects, patients with Wilson's disease and relatives of patients with Wilson's disease

✍ G.E. Cartwright; H. Markowitz; G.S. Shields; M.M. Wintrobe 📂 Article 📅 1960 🏛 Elsevier Science 🌐 English ⚖ 959 KB

The ontogeny of liver copper metabolism

The ontogeny of liver copper metabolism in the guinea pig: Clues to the etiology of Wilson's disease

✍ Surjit K. S. Srai; Andrew K. Burroughs; Bernard Wood; Owen Epstein 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 625 KB

The normal human neonate has a copper profile indistinguishable from Wilson's disease, and we have previously postulated that this disease is caused by genetic failure to switch from the fetal to adult mode of copper metabolism. This study validates the developing guinea pig as a suitable animal in

439 COMPARATIVE STUDY OF MORNING URINE C

439 COMPARATIVE STUDY OF MORNING URINE COPPER TO ZINC RATIO AND 24 H URINARY COPPER EXCRETION FOR THE DIAGNOSIS OF WILSON'S DISEASE IN CHILDREN

✍ Y. Lu; J.S. Wang; X.H. Wang; Q.R. Zhu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 39 KB

A multicentre, randomized, double-blind,

A multicentre, randomized, double-blind, placebo-controlled study to evaluate the efficacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate Alzheimer's disease: the MALT study

✍ Bruno Dubois; Ian McKeith; Jean-Marc Orgogozo; Owen Collins; Didier Meulien 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 3 views

Background. Metrifonate is a long-lasting acetylcholinesterase inhibitor being developed for the symptomatic treatment of Alzheimer's disease (AD). Objectives. This study compared the ecacy, tolerability and safety of two doses of metrifonate in patients with mild-to-moderate AD, over a 26-week tre